MedPath

Ceftriaxone

These highlights do not include all the information needed to use CEFTRIAXONE FOR INJECTION safely and effectively. See full prescribing information for CEFTRIAXONE FOR INJECTION. CEFTRIAXONE FOR INJECTION, USP Ceftriaxone for Injection, for intravenous use Initial U.S. Approval: 1984

Approved
Approval ID

5cd2d96f-83e5-4326-ae87-d0ede4ba493a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 15, 2023

Manufacturers
FDA

Samson Medical Technologies, LLC

DUNS: 102837429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftriaxone Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66288-6100
Application NumberANDA090057
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 7, 2016
FDA Product Classification

INGREDIENTS (1)

CEFTRIAXONE SODIUMActive
Quantity: 100 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ceftriaxone - FDA Drug Approval Details